Interestingly, monocyte PD-L1 was associated with disease severity and infection risk in cirrhosis while anti-PD-L1 mAb treatment restored the phagocytic capacity of macrophages and reduced bacterial dissemination in mice with chronic liver injury (228). Here, CD274 is linked to Cirrhosis.